SPARC is a possible predictive marker for albumin-bound paclitaxel in non-small-cell lung cancer

OBJECTIVES: Nanoparticle albumin-bound paclitaxel (nab-paclitaxel) produced good tumor response in cases with lung squamous cell carcinoma, one of the most difficult cancers to treat. Secreted protein acidic and rich in cysteine (SPARC) binds to albumin, suggesting that SPARC plays an important role...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Onco Targets Ther
Autori principali: Komiya, Kazutoshi, Nakamura, Tomomi, Nakashima, Chiho, Takahashi, Koichiro, Umeguchi, Hitomi, Watanabe, Naomi, Sato, Akemi, Takeda, Yuji, Kimura, Shinya, Sueoka-Aragane, Naoko
Natura: Artigo
Lingua:Inglês
Pubblicazione: Dove Medical Press 2016
Soggetti:
Original Research
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5089830/
https://ncbi.nlm.nih.gov/pubmed/27822069
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S114492
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi